Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: THE GENEVA FOUNDATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2020-06-11 to 2023-06-15
Current total value of award: $248286.04
Description: CELLULAR ENGINEERING FOR THE CREATION OF COAGULATION FACTOR-BASED RESUSCITATION FLUID TO COMBAT HEMORRHAGE AND COAGULOPATHY